Permira is taking Squarespace private in $6.9 billion deal
Related Articles
-
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
It's a major turnaround for a drug company that warned last year about its ability to stay in business.
-
Novavax shares skyrocket on $1.2 billion Sanofi vaccine deal
Novavax (NVAX) shares are skyrocketing after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu shot. Yahoo Finance's Anjalee Khemlani joins The Morning Brief to report more on the story. The Novavax-Sanofi deal also includes co-commercialization of the COVID-19 vaccine currently on the market. Novavax will be entitled to an additional $200 million for any new vaccines involving its adjuvant. Sanofi will receive a minority stake of less than 5% in...
-
Novavax soars on $1.2 billion Sanofi vaccine licensing deal
Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot.